| Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study JE Salem, A Manouchehri, M Moey, B Lebrun-Vignes, L Bastarache, ... The Lancet Oncology 19 (12), 1579-1589, 2018 | 849 | 2018 |
| Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study DB Johnson, A Manouchehri, AM Haugh, HT Quach, JM Balko, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 271 | 2019 |
| Cardiovascular toxicities associated with ibrutinib JE Salem, A Manouchehri, M Bretagne, B Lebrun-Vignes, JD Groarke, ... Journal of the American College of Cardiology 74 (13), 1667-1678, 2019 | 210 | 2019 |
| Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities Y Allenbach, C Anquetil, A Manouchehri, O Benveniste, O Lambotte, ... Autoimmunity reviews 19 (8), 102586, 2020 | 89 | 2020 |
| Tyrosine kinase inhibitors in leukemia and cardiovascular events: from mechanism to patient care A Manouchehri, E Kanu, MJ Mauro, AW Aday, JR Lindner, J Moslehi Arteriosclerosis, thrombosis, and vascular biology 40 (2), 301-308, 2020 | 52 | 2020 |
| Renin-angiotensin-aldosterone system modulates blood pressure response during vascular endothelial growth factor receptor inhibition WJ Bottinor, MM Shuey, A Manouchehri, EH Farber-Eger, M Xu, D Nair, ... Cardio Oncology 1 (1), 14-23, 2019 | 21 | 2019 |
| Spectrum of cardiovascular toxicities of immune checkpoint inhibitors: A pharmacovigilance study JE Salem, A Manouchehri, M Moey, B Lebrun-Vignes, L Bastarache, ... The Lancet. Oncology 19 (12), 1579, 2018 | 18 | 2018 |
| Solid organ transplant rejection associated with immune-checkpoint inhibitors S Saberianfar, LS Nguyen, A Manouchehri, B Lebrun-Vignes, JJ Moslehi, ... Annals of Oncology 31 (4), 543-544, 2020 | 15 | 2020 |
| Genetic Thyrotropin Regulation of Atrial Fibrillation Risk Is Mediated Through an Effect on Height JDM Mingjian Shi, Ali Manouchehri, Christian M Shaffer, Nataraja Sarma ... The Journal of Clinical Endocrinology & Metabolism 106 (7), 2124–2132, 2021 | 9 | 2021 |
| The genetic architecture of plasma kynurenine includes cardiometabolic disease mechanisms associated with the SH2B3 gene M Bagheri, C Wang, M Shi, A Manouchehri, KT Murray, MB Murphy, ... Scientific reports 11 (1), 15652, 2021 | 4 | 2021 |
| Identification of Cardiovascular Adverse Effects Associated With Midostaurin-A WHO Pharmacovigilance Database Analysis A Choudhary, A Manouchehri, J Moslehi, J Salem Circulation 142 (Suppl_3), A12978-A12978, 2020 | 3 | 2020 |
| Identification of Clinical Drivers of Left Atrial Enlargement Through Genomics of Left Atrial Size V Agrawal, A Manouchehri, NS Vaitinadin, M Shi, M Bagheri, DK Gupta, ... Circulation: Heart Failure 17 (1), e010557, 2024 | 1 | 2024 |
| HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer. J Clin Oncol 41, 2023 (suppl 16; abstr TPS5108) 41 ((suppl 16)), abstr TPS5108, 2023 | | 2023 |
| To whom correspondence should be addressed M Shi, AM Manouchehri, CM Shaffer, NS Vaitinadin, JN Hellwege, ... | | 2021 |
| Phénotype et pronostic des atteintes systémiques induites sous inhibiteurs de check-points immunitaires C Anquetil, JE Salem, A Manouchehri, O Lambotte, B Lebrun-Vignes, ... La Revue de Médecine Interne 40, A72, 2019 | | 2019 |
| Cardiovascular toxicity of ibrutinib: a pharmacovigilance study JE Salem, A Manouchehri, MA Bretagne, BL Vignes, JD Groarke, ... EUROPEAN HEART JOURNAL 40, 893-893, 2019 | | 2019 |
| P1591 Cardiovascular toxicity of ibrutinib: a pharmacovigilance study JE Salem, A Manouchehri, M arie Bretagne, B Lebrun Vignes, JD Groarke, ... European Heart Journal 40 (Supplement_1), ehz748. 0350, 2019 | | 2019 |
| ACEI and ARB Use Modulates Blood Pressure Response During Initiation of Vascular Endothelial Growth Factor Receptor Inhibition W Bottinor, A Manouchehri, MM Shuey, E Farber-Eger, JE Salem, ... Circulation 138 (Suppl_1), A15890-A15890, 2018 | | 2018 |
